KR20200084877A - 근육 이영양증을 치료하기 위한 이다살론익센트 투약 레지멘 - Google Patents
근육 이영양증을 치료하기 위한 이다살론익센트 투약 레지멘 Download PDFInfo
- Publication number
- KR20200084877A KR20200084877A KR1020207015893A KR20207015893A KR20200084877A KR 20200084877 A KR20200084877 A KR 20200084877A KR 1020207015893 A KR1020207015893 A KR 1020207015893A KR 20207015893 A KR20207015893 A KR 20207015893A KR 20200084877 A KR20200084877 A KR 20200084877A
- Authority
- KR
- South Korea
- Prior art keywords
- dose
- hours
- administered
- compound
- certain embodiments
- Prior art date
Links
- UAEPNZWRGJTJPN-UHFFFAOYSA-N CC1CCCCC1 Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762581981P | 2017-11-06 | 2017-11-06 | |
US62/581,981 | 2017-11-06 | ||
PCT/US2018/059283 WO2019090271A1 (en) | 2017-11-06 | 2018-11-05 | Edasalonexent dosing regimen for treating muscular dystrophy |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20200084877A true KR20200084877A (ko) | 2020-07-13 |
Family
ID=66332350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020207015893A KR20200084877A (ko) | 2017-11-06 | 2018-11-05 | 근육 이영양증을 치료하기 위한 이다살론익센트 투약 레지멘 |
Country Status (16)
Country | Link |
---|---|
US (1) | US20210023029A1 (pt) |
EP (1) | EP3706730A4 (pt) |
JP (1) | JP2021502328A (pt) |
KR (1) | KR20200084877A (pt) |
CN (1) | CN111315372A (pt) |
AU (1) | AU2018359969A1 (pt) |
BR (1) | BR112020009020A2 (pt) |
CA (1) | CA3078727A1 (pt) |
CL (1) | CL2020001180A1 (pt) |
CO (1) | CO2020006395A2 (pt) |
IL (1) | IL274375A (pt) |
MX (1) | MX2020004659A (pt) |
PH (1) | PH12020550526A1 (pt) |
RU (1) | RU2020118258A (pt) |
SG (1) | SG11202004115WA (pt) |
WO (1) | WO2019090271A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020191087A1 (en) * | 2019-03-18 | 2020-09-24 | Ptc Therapeutics, Inc. | Therapeutic combinations for use in treating a muscular dystrophy |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0915536A2 (pt) * | 2008-07-08 | 2019-01-15 | Catabasis Pharmaceuticals Inc | salicilatos acetilados de ácidos graxos e seus usos |
PT2519230T (pt) * | 2009-12-31 | 2019-01-18 | Marius Pharmaceuticals Llc | Modulação de solubilidade, estabilidade, absorção, metabolismo e perfil farmacocinético de fármacos lipofílicos por esteróis |
MX337605B (es) * | 2010-01-08 | 2016-03-10 | Catabasis Pharmaceuticals Inc | Derivados de fumarato de acido graso y sus usos. |
-
2018
- 2018-11-05 CA CA3078727A patent/CA3078727A1/en not_active Abandoned
- 2018-11-05 AU AU2018359969A patent/AU2018359969A1/en not_active Abandoned
- 2018-11-05 RU RU2020118258A patent/RU2020118258A/ru unknown
- 2018-11-05 US US16/761,783 patent/US20210023029A1/en not_active Abandoned
- 2018-11-05 BR BR112020009020-4A patent/BR112020009020A2/pt not_active Application Discontinuation
- 2018-11-05 MX MX2020004659A patent/MX2020004659A/es unknown
- 2018-11-05 CN CN201880071203.6A patent/CN111315372A/zh active Pending
- 2018-11-05 EP EP18874489.0A patent/EP3706730A4/en not_active Withdrawn
- 2018-11-05 JP JP2020520142A patent/JP2021502328A/ja active Pending
- 2018-11-05 KR KR1020207015893A patent/KR20200084877A/ko unknown
- 2018-11-05 WO PCT/US2018/059283 patent/WO2019090271A1/en active Application Filing
- 2018-11-05 SG SG11202004115WA patent/SG11202004115WA/en unknown
-
2020
- 2020-04-30 IL IL274375A patent/IL274375A/en unknown
- 2020-04-30 PH PH12020550526A patent/PH12020550526A1/en unknown
- 2020-05-05 CL CL2020001180A patent/CL2020001180A1/es unknown
- 2020-05-27 CO CONC2020/0006395A patent/CO2020006395A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
PH12020550526A1 (en) | 2021-05-10 |
EP3706730A1 (en) | 2020-09-16 |
JP2021502328A (ja) | 2021-01-28 |
CL2020001180A1 (es) | 2020-09-25 |
CN111315372A (zh) | 2020-06-19 |
EP3706730A4 (en) | 2021-08-11 |
BR112020009020A2 (pt) | 2020-10-27 |
US20210023029A1 (en) | 2021-01-28 |
IL274375A (en) | 2020-06-30 |
AU2018359969A1 (en) | 2020-05-14 |
WO2019090271A1 (en) | 2019-05-09 |
SG11202004115WA (en) | 2020-06-29 |
CO2020006395A2 (es) | 2020-06-09 |
CA3078727A1 (en) | 2019-05-09 |
MX2020004659A (es) | 2020-10-14 |
RU2020118258A (ru) | 2021-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101068603B1 (ko) | 지방 조직, 피부 조직, 피부 질환 및 근육 조직의 치료를 위한 제제 | |
JP7033642B2 (ja) | 選択的s1p1レセプターアゴニストを含む薬学的合剤 | |
JP7053478B2 (ja) | Fxrアゴニストを使用するための方法 | |
CA3121920A1 (en) | Crf1 receptor antagonist, pharmaceutical formulations and solid forms thereof for the treatment of congenital adrenal hyperplasia | |
AU2016304737B2 (en) | Methods of sedation and parenteral formulation for use during critical care treatment | |
US10583105B2 (en) | Compositions and methods for neuroprotection and treatment of neurodegeneration | |
JP2022537366A (ja) | Lpc-dha、lpc-epaなどの非経口リゾホスファチジルコリン製剤及びそれらの治療における使用 | |
JP7175272B2 (ja) | 筋萎縮の治療におけるトリプトファン代謝物質の使用 | |
JP2022543837A (ja) | てんかん重積状態の治療に使用するためのガナキソロン | |
KR20200084877A (ko) | 근육 이영양증을 치료하기 위한 이다살론익센트 투약 레지멘 | |
WO2017027249A1 (en) | Methods of sedation and parenteral formulation for use during critical care treatment | |
TWI626043B (zh) | 苯甲酸鋰用於治療中樞神經系統疾病的用途 | |
WO2019088881A1 (ru) | Комбинации эдаравона для лечения ишемических повреждений мозга | |
WO2021004422A1 (zh) | 小分子PI4KIIIα抑制剂组合物、其制备方法及用途 | |
US20160228353A1 (en) | Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation | |
AU2018298431A1 (en) | Use of edaravone in oral treatment of oxidative-stress mediated neurodegenerative disorders | |
CN112654626A (zh) | 化合物及其用途 | |
CA3204701A1 (en) | Topical pharmaceutical compositions and methods | |
EP3607948A1 (en) | Tissue transglutaminase modulators for medicinal use | |
US20230333087A1 (en) | Methods for monitoring patient response to treatment of retinal oxidative diseases | |
KR20180030025A (ko) | 질환의 치료를 위한 헤테로아릴 카보나이트릴 | |
US20230277491A1 (en) | Pharmaceutical combination comprising glycolic acid and l-alanine | |
US20210121425A1 (en) | Electrophilic nitroalkene benzoic acid derivates as therapeutic drugs in amyotrophic lateral sclerosis (als) and other neurodegenerative conditions | |
KR20240109697A (ko) | 나프토퀴논계 화합물을 포함하는 조성물 및 연질 캡슐 제형 | |
EA043008B1 (ru) | Комбинации эдаравона для лечения ишемических повреждений мозга |